Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Mar 21;17(3):e0263917. doi: 10.1371/journal.pone.0263917

Nonlinear molecular dynamics of quercetin in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection

Arabinda Ghosh 1,#, Pranjal Sarmah 2,#, Harun Patel 3, Nobendu Mukerjee 4, Rajbardhan Mishra 5, Saad Alkahtani 6,*, Rajender S Varma 7, Debabrat Baishya 2,*
Editor: Ghulam Md Ashraf8
PMCID: PMC8936497  PMID: 35313329

Abstract

Liver performs number of critical physiological functions in human system. Intoxication of liver leads to accumulation of free radicals that eventually cause damage, fibrosis, cirrhosis and cancer. Carbon tetrachloride (CCl4) belongs to hepatotoxin is converted to a highly reactive free radical by cytochrome P450 enzymes that causes liver damage. Plant extracts derived quercetin has substantial role in hepatoprotection. This study highlights the possible mechanism by which quercetin plays significant role in hepatoprotection. HPLC analysis revealed the abundance of quercetin in the fruit extracts of Gynocardia odorata and Diospyros malabarica, were isolated, purified and subjected to liver function analysis on Wistar rats. Post quercetin treatment improved liver function parameters in the hepatotoxic Wistar rats by augmenting bilirubin content, SGOT and SGPT activity. Gene expression profile of quercetin treated rats revealed down regulation of HGF, TIMP1 and MMP2 expressed during CCl4 induction. In silico molecular mechanism prediction suggested that quercetin has a high affinity for cell signaling pathway proteins BCL-2, JAK2 and Cytochrome P450 Cyp2E1, which all play a significant role in CCl4 induced hepatotoxicity. In silico molecular docking and molecular dynamics simulation have shown that quercetin has a plausible affinity for major signaling proteins in liver. MMGBSA studies have revealed high binding of quercetin (ΔG) -41.48±11.02, -43.53±6.55 and -39.89±5.78 kcal/mol, with BCL-2, JAK2 and Cyp2E1, respectively which led to better stability of the quercetin bound protein complexes. Therefore, quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL-2, JAK2 and Cyp2E1.

Introduction

Liver plays a crucial role in the detoxification of xenobiotic compounds, toxins, and chemotherapeutic drugs alongside its usual function of metabolism, secretion, and storage. Carbon tetrachloride (CCl4), a potent hepatotoxin, is activated by the enzyme cytochrome P450 in endoplasmic reticulum. It causes the synthesis of highly reactive free radical products followed by lipid peroxidation in liver [1]. Hepatic tissue injury is instigated by those free radical derivatives mediated by lipid peroxidation [1]. The liver microsomal cytochrome P450 interceded lipid peroxidation and tissue damage by trichloromethyl free radicals are well established facts [24]. In addition, many cell signal-transducing proteins as well as major transcription activator elements e.g., SATA3, JAK2 (Janus Kinase 2), and BCL-2 (B-cell lymphoma-2) etc. are upregulated by CCl4 resulting in hepatotoxic effects [5]. CCl4-induced hepatotoxicity, on the other hand, exhibited apoptotic response declination by increasing BCL-2 (B-cell lymphoma-2) related putative X protein and downregulating apoptotic regulator BCL-2; thus, BCL-2 was demonstrated to be a key role on regulatory pathway in cancer development [6].

Medicinal plants have traditionally been used to cure several diseases, including liver disorders, without causing much toxic side effects. Numerous plants have been investigated hitherto against liver toxicity ailments. A few that have extensively been used includes Camellia sinensis, Picrorhiza kurroa, Glycyrrhiza glabra, Silybum marianum and Curcuma longa etc. [79]. The antioxidants present in medicinal plants may cure different diseases by offering cytoprotection from damage caused by free radicals, the highly reactive oxygen compounds [6]. Analogous to Braviscarpin’s crude flavonoid, natural flavonoids have been widely employed for the treatment of hepatotoxicity, as in the case of reversing the change in JAK2, BCL-2, and SATA3 [6]. A polymethoxy flavonoid has recently been reported to have anti-inflammatory and immunomodulatory action in enhancing BCL-2 to lower the effect of CCL4-induced hepatotoxicity [10]. Silybum marianum derivedcompound, silymarin, has profound antioxidant and hepatoprotective activity as it inhibits the free radical induced liver toxicity produced from CCl4, acetaminophen and ethanol [11]. In another report, Mahli and coworkers investigated the potent hepatoprotective activity of silymarin in rats having acute liver injury [1].

Quercetin, an important dietary flavonoid has a wide range of health benefits, including antioxidative, anti-inflammatory, and anti-apoptotic attributes [12]. Quercetin has been shown to present in many plants and this flavonoid has been shown to protect cells against oxidative stress caused by xenobiotics [13, 14]. Furthermore, quercetin has been shown to protect liver from hepatotoxin-induced damage [15]. Due to its antioxidant properties in addition to hepatoprotective action, bark extract of Diospyros malabarica (Ders.) Kostel has been reported to possess a wide range of therapeutic applications. [16] The seed extracts of Gynocardia odorata R. Br. hasbeen used traditionally as anti-diabetic and antiulcer agent. For instance, phytoconstituents from methanolic extract of Gynocardia odorata R.Br. were reported to encompass many antidiabetic, anti-inflammatory and hepatoprotective compounds [17]. Diospyros malabarica and Gynocardia odorata has been reported to contain quercetin [18]. Owing to high importance and usefulness of these two medicinal plants, the present investigation has centered on the evaluation of quercetin responsible for hepatoprotective efficacy from the fruit extracts of Diospyros malabarica and Gynocardia odorata and understanding the possible mechanistic role in hepatoprotection.

Materials and methods

Chemicals

Methanol, DPPH, Ascorbic acid, Gallic acid, Hydrogen peroxide, and CCl4 were procured from HiMedia Pvt. Ltd., India. RNA isolation kit and cDNA synthesis kit were procured from Life Technologies, India.

Collection of plant material and extract preparation

The fruits of D. malabarica and G. odorata were procured from the province of Nilachal hill, Kamrup, Assam, India (26°11′0″N 91°44′0″E). Fruits were rinsed thoroughly with distilled water, carved, dried, powdered and stored at 4°C for further analysis. The collected plants were subjected to harbarium preparation and followed by identification at GUBH, the Dept. of Botany, Gauhati University, Assam, India. Nevertheless, accession numbers were assigned to the individual plants as D. malabarica (Acc. No. 18071 dt.04.11.2015) and G. odorata (Ac.No. 18072dt.04.11.2015).

Qualitative and quantitative estimation of phytochemicals

Methanolic extract (70% v/v) of fruit samples of D. malabarica and G. odorata were prepared to estimate the phytochemicals such as flavonoids, tannins, saponins and alkaloids qualitatively as described earlier by Trease and Evans [19]. Bio-macromolecules viz. total protein, total carbohydrates present in the fruit extracts were estimated as per Lowry’s method and Anthrone method, respectively [20, 21]. The presence of ascorbic acid in the fruit extract was measured in 4% oxalic acid by titrating against the 2,6-dichlorophenolindophenoldye until pink color appeared for confirmation. Folin-Ciocalteau’s approach was used to determine the total phenol contents in the fruit extract [22]. In-vitro antioxidant activities of quercetin and histopathological studies of liver were performed, and details incorporated in the S1 File.

HPLC analysis of plant extracts

Quercetin (QR), a polyphenolic flavonoid compound, is found in large amounts in fruit extracts derived from plants, which protects against oxidative stress and hepatotoxicity [23]. The abundance of quercetin as an active component in the fruit extracts of D. malabarica and G. odorata, was determined using HPLC (SYS-LC-138, Systronics, India). A mobile phase was preparedusing a mixture of 0.1% (v/v) methanol and (65:35%, v/v) ortho-phosphoric acid. The adjusted flow rate of mobile phase was 1.0 ml/min in the column (4.6 mm × 250 mm × 5μM, HiQ Sil C18-HS) and temperature maintained at 28°C, while the injection volume was kept at 20 μL. An isocratic elution was carried out per sample for 15 min.

Animals

A total of 30 Wistar albino rats (either sex) (8 to 12 weeks old), weighing from 100 g to 120 g were used in this study. The rats were kept in animal house of Gauhati University and acute oral toxicity OECD/OCED (423) guideline for the testing of selected plant samples (OECD/OCED (423) was followed in cages (6 Wistar albino rats per group/3 male and 3 female) under normal laboratory condition of humidity, temperature (22–25 oC) and light (12/12 hour light dark cycle.) [24]. Animal models were fed with Normal pellet diet.

Ethics statement

All procedures performed in studies involving animal models were in accordance with the ethical standards of the institutional ethics committee (Animal ethical committee, Gauhati University, Ref. No. IAEC/PER/2014-2015/01; 08/05/2015).

Experimental design

Acute toxicity study for purified flavonoid quercetin from the fruits extracts of Diospyros malabarica and Gynocardia odorata was carried out as per the OECD guidelines for testing chemicals [24]. The Wistar rats received doses of methanolic extracts of the fruits orally which was prepared one day prior to oral dose in various concentrations viz: 50, 100, 200, 500, 1000, 1500 and 2000 mg/kg body weight of the animals respectively. Animal lay-up conditions (described in the previous section) were maintained at least for 7 days prior to dosing with free access to water and food ad libitum for acclimatization to the laboratory conditions. Five groups (A-E) of 6 rats each of either sex were used for the CCl4-induced hepatotoxicity model. CCl4 (10% in liquid paraffin, 1 mL/kg per day for seven consecutive days) was administered orally to induce liver injury in the four groups (B-E) [4]. 200 mg/kg body weight each of D. malabarica, G. odorata, and Silymarin were administered orally to these groups of animals at 2, 24 and 48 h interval after the administration of the last dose of CCl4 (Table 1).Two hours after the final dose of extracts, Silymarin and saline water, all the animals were sacrificed.

Table 1. Experimental design in five different groups of rats including control, silymarin and plant extracts of D. malabarica and G. odorata.

Name of Groups No. of rats in each group Details of group Treatment details
GROUP A 6 Negative control Normal saline water
GROUP B 6 Negative control CCl4
GROUP C 6 Positive control CCl4 + Silymarin (200 mg/kg body weight)
GROUP D 6 Treatment group CCl4 + quercetin D. malabarica (200 mg/kg body weight)
GROUP E 6 Treatment group CCl4 + quercetin G. odorata (200 mg/kg body weight)

The resulting body weight after fasting of each animal was determined and the dose is calculated according to the body weight. Food was withdrawn for next 3–4 hours in rats after the extract has been administered. The animals were observed for toxic symptoms continuously for the first 4 hours after dosing followed by their mortality and behavioral response for 48 hours. This observation was followed daily for a total of 14 days. Individual weights of animals were determined before the fruit extracts were administered. Change in body weight was calculated and recorded each day. From the collected blood samples, serum was tested for liver markers such as total protein (TP), albumin (Alb), globulin (Glob), total bilirubin, SGOT, SGPT, etc. Invitro antioxidant activity of fruit extracts and the histopathological studies were performed and details have been given in S1 File.

Gene expression profiling and real time PCR analysis

Expression profiling of gene markers i.e., hepatocyte growth factor (HGF), metalloproteinase tissue inhibitor (TIMP1) and Matrix metalloproteinase (MMP2) were carried out from the extracted liver of different groups of experimental rats. RNA was extracted using QIAamp RNA Blood Mini Kit from the frozen liver as suggested by the manufacturer. RNA quantification for purity was analyzed using a spectrophotometer (Cary50, Agilent, Germany) and followed by cDNA synthesis following similar methods employed elsewhere [17]. Two endogenous housekeeping genes, hypoxanthine peptidylprolyl isomerase A (Ppia) and phosphoribosyltransferase 1 (Hprt1) were used to compare the relative amount of the transcripts in all groups [25].

Molecular redocking for validation of docking score

Liver cytochrome P450 2E1 (Cyp2E1) belongs to the family of cytochrome P450 enzyme that plays a vital role in toxin, alcohol, drug, lipid, and carcinogen metabolism [26]. Molecular docking studies were carried out between the target protein Cyp2E1, silymarin and quercetin. The three-dimensional coordinates of Cyp2E1 X-ray 1.8 Ǻ resolution in pdb format was downloaded from RCSB PDB repository (PDB ID: 3T3Z). Two other major cell signaling proteins JAK2 and BCL-2 were also investigated for understanding the mechanism of quercetin action. The coordinate files for JAK2 (PDB ID: 2B7A) with atomic resolution 2.00 Å and for BCL-2 (PDB ID: 4IEH) atomic resolution 2.10 Å were fetched from protein databank for further analysis. 3D structures of quercetin and silymarin were procured from public database pubchem (https://pubchem.ncbi.nlm.nih.gov/compound/quercetin#section=Top) in SDF format and subsequently converted in pdb format using OpenBabel 2.2.3 [27]. Autodock version v 4.2.1 was used for the molecular docking studies. During molecular docking studies, three replicates were performed having the total number of solutions computed 50 in each case, with population size 500, number of evaluations 2500000, maximum number of generations 27000 and rest the default parameters were allowed. After docking, the RMSD clustering maps were obtained by re-clustering with a clustering tolerance 0.5 Å,1 Å and 2 Å, respectively, in order to obtain the best cluster having lowest energy score with high number of populations.

In order to obtain accurate binding affinities for quercetin QM-Polarized Ligand Docking (QPLD) was performed using Schrodinger 2018–4 package (https://www.schrodinger.com/qm-polarized-ligand-docking). Quantum mechanics ligand docking gave accurate treatment of electrostatic charges to quercetin to avoid charge polarization induced by the Cyp2E1, BCL-2 and JAK2 environment. QPLD combines the docking power of Glide with the accuracy of QSite in QM/MM software. To perform QM docking, glide docking was executed within a grid size of (nx, ny, nz) Å = (200, 208, 200) for Cyp2E1, Å = (69, 80, 65) for BCL-2 and Å = (81, 98, 76) for JAK2 proteins followed by addition of QM charges using Jaguar tool embedded in the Schrodinger 2018–4 package. Then redocking was performed in high precision with an approximate ligand van der Waals spacing 0.8 Å and maximum atomic displacement 1.3 Å. A maximum of 10 ligand docking poses were generated with RMS deviation 0.5 Å.

Molecular dynamics simulation (MD) and free energy landscape analysis

The MD simulations studies were carried out in triplicate on the QPLD dock complexes for BCL-2, JAK2 and Cyp2E1 with quercetin using the Desmond 2020.1 from Schrödinger, LLC. The triplicate samplings were made using same parameters for each MD run in order to obtain reproducibility of the results. The OPLS-2005 force field [2830] and explicit solvent model with the SPC water molecules were used in this system [31]. Na+ ions were added to neutralize the charge. 0.15 M, NaCl solution was added to the system to simulate the physiological environment. Initially, the system was equilibrated using NVT ensemble for 100 ps to retrainover the protein-quercetin complex. Following this step, a short run of equilibration and minimization were carried out using NPT ensemble for 12 ps.The NPTensemble was set up using the Nose-Hoover chain coupling scheme [32] with temperature at 27°C, the relaxation time of 1.0 ps and pressure 1 bar maintained throughout the simulations. A time step of 2 fs was used. The Martyna-Tuckerman–Klein chain coupling scheme [33] barostat method was used for pressure control with a relaxation time of 2 ps. The particle mesh Ewald method [34] was used for calculating long-range electrostatic interactions, and the radius for the coulomb interactions were fixed at 9Å. RESPA integrator was used for a time step of 2 fs for each trajectory to calculate the bonded forces. The root means square deviation (RMSD), radius of gyration (Rg), root mean square fluctuation (RMSF) and number of hydrogen (H-bonds) were calculated to monitor the stability of the MD simulations. Free energy landscape of protein folding on quercetin bound complex was measured using geo_measures v 0.8 [35]. Geo_measures include powerful library of g_sham and form the MD trajectory against RMSD and radius of gyration (Rg) energy profile of folding recorded in a 3D plot using matplotlib python package.

Molecular Mechanics Generalized Born and Surface Area (MMGBSA) calculations

The binding free energy (ΔGbind) of the docked complexes during MD simulations of BCL-2, JAK2 and Cyp2E1 complexed with quercetin were estimated using the molecular mechanics generalized born surface area (MMGBSA) module (Schrodinger suite, LLC, New York, NY, 2017–4). The OPLS 2005 force field, VSGB solvent model, and rotamer search algorithms were used to define the binding free energy during the calculation [36]. The MD trajectories frameswere selected at each 10 ns interval after MD run. The Eq 1 was used to calculate the total free energy binding:

ΔGbind=Gcomplex(Gprotein+Gligand) (1)

Where, ΔGbind = binding free energy, Gcomplex = free energy of the complex, Gprotein = free energy of the target protein, and Gligand = free energy of the ligand. The MMGBSA outcome trajectories were analyzed further for post dynamics structure modifications.

Dynamic cross correlation and principal component (PCA) analysis

In order to analyze the domain correlations, dynamic cross correlation matrix (DCCM)was generated across all Cα-atoms for all the complexes during the MD simulation of 100 ns. PCA analysis was performed to extract the global motions of the trajectories during 100 ns simulation of BCL-2, JAK2 and Cyp2E1 complexed with quercetin. A covariance matrix was generated to calculate the PCA as described elsewhere [37]. 20 different conformational modes of principal component as the motion of trajectories were calculated and a comparison of first highest mode (PC1), with PC2, PC3 and PC20 analyzed for conformational analysis of the quercetin bound complex. Free energy landscape of protein folding on quercetin bound complex was measured using geo_measures v 0.8 [35]. Geo_measures include powerful library of g_sham and form the MD trajectory PC1, PC2, PC3 and PC20 mode were recorded in a 3D plot using matplotlib python package.

Results

Screening of phytochemicals in the fruit extracts of D. malabarica and G. odorata

The active phytochemicals screening in qualitative analysis revealed that the methanolic fruit extracts of D. malabarica and G. odorata were well endowedwith flavonoids, tannins, saponins, ascorbic acid and alkaloids. The other biochemicals were determined quantitatively: carbohydrate (%, w/v) 8.56 ± 0.20 and 9.25 ± 0.38, protein (%, w/v) 4.77 ± 0.17 and 3.52 ± 0.24, significant quantities of phenolic content (μg GAE/mg) 223.5 ± 0.26 and 206.14 ± 0.52 and ascorbic acid content (mg/100g) 55.57 ± 0.75 and 42.66 ± 0.83.

HPLC analysis of plant extracts

HPLC analysis of Diospyros malabarica and Gynocordia odorata fruit extracts displayed the abundance of a peak at retention time 1.512 minute (Fig 1A and 1C) which corroborated with the standard quercetin exhibiting retention time at 1.513 minutes (Fig 1B). The purified fraction of quercetin was collected using a fraction collector (FRC-10A, Shimadzu, Japan) and the fractions were pulled into a final concentration of 25μg/mL. Purity of the extracted quercetin from fruit extracts were determined by comparing with the standard Quercetin in HPLC. Hence, quercetin is one of the abundant bioactive molecules present in the D. malabarica and G. odorata fruit extracts which might possesses the hepatoprotective activity.

Fig 1.

Fig 1

HPLC profile with retention time of quercetin compound from fruit extracts of (A) Diospyros malabarica and (C) Gynocordia odorata fruit extracts. (B) Profile of standard quercetin molecule. (D) Gene expression profile in real time PCR of quercetin on Group D and E rats.

Liver function analysis

Experimentally designed groups of Wistar rats were observed continuously for any abnormalities as a result of toxicity such as writhing, gasping, palpitation and respiratory rate, or mortality. The liver function analysis is displayed in Table 2. Histopathology study was explained in detail in S1 File. The oral dose of Diospyros malabarica and Gynocordia odorata fruit extracts did not display any mortality neither showed any signs of toxicity at an applied dose 2000 mg/kg body weight. The effect of fruit extracts from Diospyros malabarica and Gynocordia odorata displayed lowering of bilirubin 0.41±0.007 g/dl and 0.45±0.005, SGOT 127.25±2.02 and 132.15±2.17 U/mL, SGPT 83.58±1.78 and 87.82±1.56 U/mL, respectively, as compared to the hepatotoxic rats treated with CCl4 and the results were quite comparable with silymarin treated rats. In some cases, e.g., the quantities of SGPT and SGOT, in fact,were comparatively lower than the commercial drug silymarin treated rats. On the other hand, quantities of total protein, albumin and globulin did not show much significant variance among the control and treated groups (Table 2). Significant free radical scavenging activities of quercetin present in Diospyros malabarica and Gynocordia odorata fruit extracts against DPPH and H2O2 were also observed (S1 File). Histopathological studies of rat liver displayed the ameliorating pattern after treatment with quercetin containing Diospyros malabarica and Gynocordia odorata fruit extracts (S1 File).

Table 2. Effects of methanolic extract from Diospyros malabarica and Gynocardia odorata on liver Total protein, Albumin, Globulin, Total bilirubin, SGOT and SGPT on CCl4 induced hepatotoxicity in rats.

Groups Total protein
(g/dL)
Albumin
(g/dL)
Globulin (g/dL) Total bilirubin (g/dL) SGOT (U/mL) SGPT(U/mL)
Control 6.84±0.14 3.95±0.37 3.28±0.14 0.26±0.014 80.64±1.22 41.98 ±1.60
CCl4 treated (1mL/kg) 5.36±0.12 2.62±0.22 2.60±0.06 0.69±0.009 189.20±3.95 102.42±1.59
CCl4 + Silymarin (200 mg/kg) 6.47±0.06 3.28±0.10 3.19±0.06 0.32±0.004 109.12±1.51 69.54±2.01
CCl4+ quercetin D. malabarica (200 mg/kg) 6.16±0.26 3.12±0.06 3.00±0.26 0.41±0.007 127.25±2.02 83.58±1.78
CCl4+ quercetin G. odorata (200 mg/kg) 5.94±0.31 2.98±0.08 3.13±0.21 0.45±0.005 132.15±2.17 87.82±1.56

Gene expression profiling

Integrity of RNA

The 260/280 ratio for the RNA isolated from the liver tissue samples ranged from 2.08–2.14 suggesting good quality RNA (Table ST3 in S2 File). The integrity of RNA was checked on agarose gel showing discrete 28S and 18S ribosomal RNA band on each sample suggesting that the RNA in each case was intact and could be used for qPCR analysis (Fig S3 in S2 File).

Real time PCR analysis

In the qPCR analysis, high expression of genes, hepatocyte growth factor (HGF), the tissue inhibitors metalloproteinase (TIMP1) and Matrix metalloproteinase (MMP2) from the liver tissue of animal models were observed in the CCl4 treated animals (Group B) (Fig 1D). In contrast, down regulation of these were noted for positive control (Group C), treated with commercial drug silymarin as well as in the Group D treated with quercetin obtained from D. malabarica and G. odorata (Group E) (Fig 1D). Hprt1 and Ppia were used as housekeeping genes for this study. The qPCR outcome was examined using the students t-test (P< = 0.05) (Group B versus other groups individually).

Molecular redocking for validation of docking score

In molecular docking analysis of BCL-2, JAK2 and Cytochrome P450 Cyp2E1 with the ligand quercetin in Autodock output, the best conformation was displayed in a dock complex (Table 3). The best dock pose was seleccted based on low RMSD tolerance 0.5 Å and binding energy having maximum within that RMSD cluster. BCL-2-quercetin complex showed free energy of binding (Δ;G) -8.7 kcal/mol, inhibitory concentration 5.06 μM, ligand efficiency -0.5, total internal energy -3.1 kJ/mol, and tortional energy 1.25 kJ/mol. The principal residues making the binding pocket around quercetin is comprised of Phe97, Tyr101, Phe105, Leu108, Glu129, Leu130, Asp133, Arg139, Ala142, Ser145 (Fig 2A). On the other hand, JAK2-quercetin complex displayed free energy of binding (Δ;G) -8.8 kcal/mol, inhibitory concentration 1.14 μM, ligand efficiency -0.11, total internal energy -4.1 kJ/mol, and tortional energy 0.72 kJ/mol. Residues conforming the quercetin binding pocket are Leu828, Gly829, Phe833, Lys855, Glu871, Leu900, Met902, Tyr904, Leu905, Gly908, Cys909, Arg953, Asn954, Asp967, however, Glu871 and Arg953 involved in forming conventional hydrogen bonds (Fig 2B).

Table 3. Binding energy properties of BCL-2, JAK2 and Cyp2E1 with quercetin in docking and redocking in QPLD.

Quercetin docked with ΔGbind (kcal/mol) ΔGbind(QPLD) (kcal/mol) Ki (μM) Residues at the binding site cavity
BCL -8.7 -11.41 5.06 Phe97, Tyr101, Phe105, Leu108, Glu129, Leu130, Asp133, Arg139, Ala142, Ser145
JAK -8.8 -12.02 1.14 Leu828, Gly829, Phe833, Lys855, Glu871, Leu900, Met902, Tyr904, Leu905, Gly908, Cys909, Arg953, Asn954, Asp967
Cyp2E1 -6.05 -8.71 22.01 Leu313, Met316, Pro462, Leu463, Val464, Asp468, ILE469, Asp470, Pro483, Tyr485, Lys486

Fig 2.

Fig 2

Best docked pose of quercetin with (A) BCL-2, (B) JAK2 and (C) Cytochrome P450 Cyp2E1 displaying 2D interaction plot on the left panel. Green dashed lines indicating the conventional hydrogen bonds and residues embedded in light green sphere indicating to involve in hydrophobic interactions. On the center panel, surface view of (A) BCL-2, (B) JAK2 and (C) Cytochrome P450 Cyp2E1 displaying binding cavity of quercetin and right panel displaying the zoomed out binding pocket having amino acid residues at 3Å surrounding the quercetin molecule.

The quercetin bound to Cyp2E1 with convincing binding energy (Δ;G) -6.05 kcal/mol, inhibitory concentration (Ki) 22.01 μM, ligand efficiency -0.29, total internal energy -1.8 kJ/mol and tortional energy 2.09 KJ/mol. Quercetin (ligand) in the Cyp2E1 complex exhibited Leu313, Met316, Pro462, Leu463, Val464, Asp468, ILE469, Asp470, Pro483, Tyr485, Lys486 are major amino acid residues involved in the formation of binding cavity (Fig 2C). However, Leu463, Asp470 and Lys486 were involved in conventional hydrogen bonds (Fig 2C, right panel 2D plot). The quercetin-BCL-2, JAK2 and Cyp2E1 complex docking energies were recalculated using glide, QPLD with QM and MM optimized redocking following extra precision protocol (XP) showed -11.41, -12.0 and -8.71 kcal/mol binding free energies at the same binding site used in Autodock tool, respectively. Therefore, validated docking scores confirmed significant binding of quercetin with diverse liver targets involved in cell signaling. Binding energies suggested that quercetin has good affinity for the target proteins BCL-2, JAK2 and Cyp2E1.

Molecular dynamics simulation (MD) and free energy landscape analysis

Molecular dynamics and simulation (MD) studies were carried out to determine the stability and convergence of quercetin bound protein complexes. Each simulation of 100 ns displayed stable conformation while comparing the root mean square deviation (RMSD) values. The Cα-backbone of BCL-2 bound to quercetin exhibited a deviation of 1.1 Å (Fig 3A), while JAK2 displayed comparatively stable 0.5 Å deviation (Fig 3B). On the other hand, Cα-backbone of Cyp2E1 displayed more RMS deviation as compared to BCL-2 and JAK2 with 1.5 Å fluctuation (Fig 3C). RMSD plots are within the acceptable range signifying the stability of proteins in the quercetin bound state before and after simulation.It can also be suggested that quercetin bound BCL-2, JAK2 and Cyp2E1 are quite stable in complex due to higher affinity of the ligand. Radius of gyration is the measure of compactness of the protein. Here in this study, BCL-2 backbone displayed less fluctuating radius of gyration (Rg) initially till 80 ns of simulation while later upto 100 ns became stable (Fig 3D). JAK2 backbone displayed the lowering of Rg till 85 ns but later went up to regain the compactness of the protein (Fig 3E). On the other hand, stable Rg observed in case of Cyp2E1 except a deep angle at 45 ns which has regained its shape thereafter and thus confirming significant compactness of the protein in quercetin bound state (Fig 3F). The overall quality analysis from RMSD and Rg it can be suggested that quercetin bound to the protein targets posthumously in the binding cavities and played a significant role in stability of the proteins. The plots for root mean square fluctuations (RMSF) displayed significant spike of fluctuation (7 Å) of amino acid residues Gln26 and Val30 in BCL-2 protein while the rest of the residues less fluctuating during the entire100 ns simulation (Fig 3G). RMSF plot of JAK2 displayed less fluctuation of residues of 3–4 Å indicating the stable amino acid conformations during the simulation time (Fig 3H). Cyp2E1 displayed significant amino acid fluctuations from Trp214 to Tyr274 residues while the rest of the residues were less fluctuating (Fig 3I). Therefore, for RMSF plots it can be suggested that the proteins structures were stable during simulation in quercetin bound conformation. Quercetin formed single conventional hydrogen bond with Ser145 of BCL-2 protein at a frequency of 38% throughout simulation time. While water bridges, pi-pi and hydrophobic interactions also helped to form stable complex (Fig 3J). Quercetin bound to JAK2 with significant numbers of conventional hydrogen bonds as displayed in 2D interaction plot (Fig 3K). Glu871, Arg953 and Asp967 are the key residues in JAK2 protein formed hydrogen conventional hydrogen bonds at a frequency 95%, 62% and 33%, respectively with quercetin. On the other hand, quercetin formed hydrogen bonds with Leu463 with 50%, Asp470 with 35% and couple of hydrogen bonds with Lys486 via–OH groups of quercetin with frequencies 86% and 47% throughout the 100 ns simulation time (Fig 3L).The non-bonded interactions played critical role in quercetin and protein complex integrity. Quercetin formed an average of single hydrogen bond with BCL-2 (Fig 3M) whereas with JAK2 confined to average 3 hydrogen bonds (Fig 3N). While Cyp2E1 displayed conventional hydrogen bond with Asp470 and Lys486 (Fig 3O).The 2D quercetin and binding cavity residues interaction plots displayed good agreements with the outcome of hydrogen bonds formation.

Fig 3. Analysis of MD simulation trajectories for 100 ns.

Fig 3

RMSD plots displaying the molecular vibrations of Cα backbone of (A) BCL-2 (B) JAK2 and (C) Cyp2E1. Radius of gyration plots for the deduction of compactness of protein (D) BCL-2, (E) JAK2 and (F) Cyp2E1. RMSF plots showing the fluctuations of respective amino acids throughout the simulation time 100 ns for (G) BCL-2, (H) JAK2 and (I) Cyp2E1. Number of Hydrogen bonds formed during the course of simulation between quercetin and (J) BCL-2, (K) JAK2 and (L) Cyp2E1. 2D interaction plot of post simulation time between the quercetin and (M) BCL-2 (N) JAK2 and (O) Cyp2E1. Free Energy Landscape displaying the achievement of global minima (ΔG, kj/mol) of (P) BCl-2 (Q) JAK2 and (R) Cyp2E1 in presence of quercetin with respect to their RMSD (Å) and radius of gyration (Rg, Å).

The free energy landscape of (FEL) of achieving global minima of Cα backbone atoms of proteins with respect to RMSD and radius of gyration (Rg) are displayed in Fig 3. BCL-2 bound to quercetin achieved the global minima (lowest free energy state) at 2.75 Å and Rg 14.65 Å (Fig 3P). The FEL envisaged for deterministic behaviour of BCL-2 to lowest energy state owing to its high stability and best conformation at quercetin bound state. While one the other hand, JAK2 Cα backbone atoms conformed into lowest energy state at RMSD 3.4 Å and Rg 19.8 Å to achieve global minima and stable state (Fig 3Q). Similarly, Cyp2E1 exhibited global minima state at 3.5 Å andRg 22.9 Å (Fig 3R). FEL is the indicator of the protein folding to attain minimum energy state and that aptly achieved due to quercetin bound state.

The energy profiles of the protein quercetin complex systems were determined to display the stability of the entire system. In this regard, the total energy (ETOT) of the BCL-2 quercetin system shownto be very stable with an average total energy -45 kcal/mol (Fig 4A, red). However, van der Waal’s energy (vdW) displayed to be merged over the total energy with an average energy -35 kcal/mol, contemplating as principal contributor to the stability of the BCL-2 quercetin complex (Fig 4A, green). In addition, coulombic interactions played minor role in the system stability and contributing an average energy -5.0 kcal/mol (Fig 4A, blue). Energy profile of JAK2-quercetin complex displayed an average of -40 kcal/mol of ETOT (Fig 4B, red), while vdW energy contributed -25 kcal/mol (Fig 4B, green) and coulombic interaction -10 kcal/mol (Fig 4B, blue). Similar behavior was also observed in case of Cyp2E1 bound quercetin system where average ETOT was measured to be -65 kcal/mol (Fig 4C, red), and contributing vdW (Fig 4C, green) and coulombic energies (Fig 4C, blue) were -22 kcal/mol and -30 kcal/mol, respectively. The high negative values indicating lowest potential energy in the individual systems to achieve global minima of protein-quercetin complex.

Fig 4.

Fig 4

Energy plot of protein (A) BCL-2 (B) JAK2 and (C) Cyp2E1 and quercetin complex system during the entire simulation event of 100 ns. The total energy (red), van der Waal’s energy (green) and coulomb energy (blue) of the entire system indicating the stability of the individual systems bound to quercetin molecule.

Molecular Mechanics Generalized Born and Surface Area (MMGBSA) calculations

MMGBSA is a popular method in calculating the binding energy of ligand to protein molecules. The estimation of the binding free energy of each of the protein-quercetin complexes, as well as the role of other non-bonded interactions energies were estimated. It is evidenced from Table 4, the binding free energy (ΔGbind) of proteins BCL-2, JAK2 and Cyp2E1 and quercetin complex, The average binding energy of the ligand quercetin with BCL-2-41.48±11.02 kcal/mol, while with JAK2–43.53±6.55 kcal/mol and with Cyp2E1–39.89±5.78 kcal/mol. The ΔGbind is influenced by of various types of non-bonded interactions, including ΔGbind Coulomb, ΔGbindCovalent, ΔGbindHbond, ΔGbindLipo, ΔGbindSolvGB and ΔGbindvdW interactions. Among all the types of interactions ΔGbindvdW, ΔGbindLipo and ΔGbindCoulomb energies contributed most to achieve the average binding energy. In contrast, ΔGbindSolvGB and ΔGbindCovalent energies contributed the lowest to attain the final average binding energies. In addition, the values of ΔGbindHbond interaction of quercetin protein complexes showed the stable hydrogen bonds with the amino acid residues. In all the complexes ΔGbindSolvGB and ΔGbindCovalent showed unfavorable energy contributions and thus opposed binding. It is observed from Fig 5A (left panel), at pre-simulation (0 ns) quercetin at the binding pocket of BCL-2 undergone substantial angular movement of the pose (curved to straight) after post simulation (100 ns) (Fig 5A, right panel). However, in JAK2 binding cavity, the ligand quercetin during pre-simulation was quite flat (Fig 4B, left panel) but later after post-simulation (at 100 ns) observed to be change in the tortional angles with an opened conformation facing toward the pocket (Fig 5B, right panel). On the other hand, Cyp2E1 bound quercetin displayed relative movement form initial position 0 ns to final 100 ns trajectory (Fig 5C, right and left panel). These conformational changes consequences the better acquisition at the binding pocket as well as the interaction with the residues for higher stability and better binding energy.

Table 4. Binding energy calculation of quercetin with BCL-2, JAK2 and Cyp2E1 and non-bonded interaction energies from MMGBSA trajectories.

Energies (kcal/mol)* BCL-2 JAK2 Cyp2E1
ΔG bind
  • -41.48±11.02

  • -43.53±6.55

  • -39.89±5.78

ΔG bind Lipo
  • -9.20±1.02

  • -9.98±0.76

  • -9.90±0.75

ΔG bind vdW
  • -35.97±5.77

  • -37.49±3.34

  • -26.91±1.28

ΔG bind Coulomb
  • -8.48±3.64

  • -16.97±4.73

  • -12.32±4.24

ΔG bind H bond
  • -0.92±0.65

  • -2.15±0.42

  • -2.10±0.55

ΔG bind SolvGB
  • 15.48±5.63

  • 23.14±2.37

  • 8.10±1.52

ΔG bind Covalent
  • 0.73±0.20

  • 1.88±0.47

  • 3.28±0.87

*Results are calculated in mean ± SD.

Fig 5.

Fig 5

MMGBSA trajectory (0 ns, before simulation and 100 ns, after simulation) exhibited conformational changes of quercetin upon bidning with the proteins (A) BCL-2, (B) JAK2 and (C) Cyp2E1. The arrows indicating the overall positional variation (movement and pose) of quercetin at the bidning site cavity.

Thus MMGBSA calculations resulted, from MD simulation trajectories well corroborated with the binding energies calculated from the docking results. Therefore, it can be suggested that the quercetin molecule has good affinity for the major targets BCL-2, JAK2 and Cyp2E1. The MMGBSA trajectories displayed the conformational changes in the quercetin to achieve the best fitting in the binding cavity of the protein.

Dynamic cross correlation and principal component (PCA) analysis

MD simulation trajectories are analysed for dynamic cross correlation among the domains within protein chains bound with quercetin molecule. For correlative dynamic motion, the cross correlation matrices of BCL-2, JAK2 and Cyp2E1 were generated and displayed in Fig 6. The blue blocks displayed in the plot indicated the residues having high correlated movement and red having least correlation. The amino acid residues of quercetin bound BCL-2 showed concerted movement of residues (Fig 6A) coformed into a α-helix (5–25, red), residues 82–122 (green) conformed into two α-helices and 125–135 conformed into partial α-helix and loop (magenta) (Fig 6A). On the other hand, quercetin bound JAK2 diplayed 92–150 residues highly correlated movement and conformed into a loop (red) (Fig 6B). However, quercetin bound Cyp2E1 displayed small blocks of correlated motion from residues 1–50, 80–100, 382–385 (Fig 6C) conformed into loop (red), α-helix (green) and a helical turn (magenta), respectively (Fig 6C).

Fig 6.

Fig 6

Dynamic Cross Correlation matrix (DCCM) of (A) BCL-2, (B) JAK2 and (C) Cyp2E1 and correlated amino acids conformed into secondary structural domains (colored) and non-correlated domains (grey) of (D) BCL-2, (E) JAK2 and (F) Cyp2E1 proteins bound with quercetin (green).

Principal component analysis (PCA) of the MD simulation trajectories for BCL-2, JAK2 and Cyp2E1 bound to quercetin molecule was analyzed to interpret the randomized global motion of the atoms of amino acid residues. This analysis interprets the more flexible scattered trajectories owing the distortion of the protein structure. The internal coordinates mobility into three-dimensional space in the spatial time of 100 ns were recorded in a covariance matrix and rational motion of each trajectories are interpreted in the form of orthogonal sets or Eigen vectors. PCA analysis of BCL-2.

MD simulation trajectory Cα atoms displayed scattered unordered orientation owing to their less equilibrated form in first three modes. The first highest mode (PC1) displayed 28.7% of the trajectories having 64.024 variance with least coordinated aggregate motion 28.717. While in the second mode (PC2) high variance 34.762 among the 15.9% trajectories with an aggregated motion 43.12 and the third mode (PC3) variance 20.106 is found among 9.0% trajectories with aggregated motion 53 (Fig 7A). However, the PC20 described very less variance 1.312 among 0.59% trajectories with aggregated motion 84.638. The combined plots of all the three PC modes displayed in Fig 7A. It is also observed from the PCA plots, as the sampling size increased upto PC mode 20 the trajectories are more aligned (Fig 7A, green). Following BCL-2 complex, quercetin bound JAK2 Cα atoms trajectory analysis displayed three distinct scattered clusters in PC1, PC2 and PC3 modes with 23.43%, 13.93% and 9.42%, respectively (Fig 7B). The variance in each mode was calculated as 90.623, 53.894 and 36.456 and aggregated motion 23.43, 37.37 and 46.80, respectively for PC1, PC2 and PC3. However, at mode PC20 the scatteredness reduced to a uniform cluster to 0.703%, variance 2.732 and aggregated motion 78.08. On the other hand, quercetin bound Cyp2E1 displayed 31.21%, 12.97% and 5.18% contribution to scattered motion of trajectories in PC1, PC2 and PC3 modes. Average variance was observed to be 197.927, 82.291 and 32.898 and aggregated motions of the trajectories were recorded 31.21, 44.195 and 49.384 respectively at PC1, PC2 and PC3. While in PC20 (Fig 7C) the observed scattered 31.21% with variance 3.398 and aggregated motion 77.822. Therefore, PCA analysis suggested that the Eigen vectors of relative aggregated motion of the trajectories became better at higher mode PC20 into a converted global motion of the trajectories during simulation indicating high ordered protein structure and conformation during quercetin bound state. Moreover, it can be suggested that the complex between quercetin and BCL-2, JAK2 and Cyp2E1 are very stable complex. The FEL between the highest mode (PC1) and lowest (PC20) in protein conformational variation are displayed in Fig 7D.

Fig 7. PCA plots of four PC modes where PC1 the highest variance and PC20 the lowest variance Eigen values.

Fig 7

PC2 and PC3 are the second and third highest variances respectively. The 3D PCA plots of among PC1, PC2 and PC3 (in left panel) and PC1, PC2 and PC20 (right panel) displayed for (A) BCL-2, (B) JAK2 and (C) Cyp2E1, bound to quercetin molecule. The round up zones in the PCA plots displaying the clustered trajectories in the respective modes. The representation of free energy landscape (FEL) against PC1 and PC2 for the proteins (D) (i) BCL-2, (ii) JAK2 and (iii) Cyp2E1, respectively.

The protein conformational stability of BCL-2 in quercetin bound state achieved due to the positive correlation motion of the MD trajectories. Moreover, highest and lowest PCA modes exhibited the more feasible and quicker thermodynamically favorable conformation of BCL-2 [Fig 7D (i)]. Whereas the FEL for JAK2 against the dominant PCA modes exhibited quick and thermodynamically favorable protein folding [Fig 7D (ii)]. This behavior is observed due to correlated motions among the dynamic trajectories in JAK2 [Fig 7D (ii)]. Cyp2E1 showed interesting FEL where the PCA mode contribution attributed for quicker thermodynamically favorable protein folding and stabilizing the conformation [Fig 7D (iii)]. Therefore, it can be suggested from the free energy landscape of proteins in quercetin bound state achieve high favorable conformations meant for higher binding and stable complex.

Discussion

Medicinal plants have phytochemicals which act as active principle against hepatio-toxins in prevention of hepatic injury. Gynocardia odorata R. Br. and Diospyros malabarica (Ders.) Kostel are two important plants endowed withmany medicinal components. The present study encompasses the presence of active flavonoid compound “quercetin” in the methanolic fruit extracts from G. odorata and D. malabarica. Fruit extracts of G. odorata and D. malabarica exhibited comparable antioxidant activity as reported from the plant extracts elsewhere [16, 38]. Earlier investigations have revealed that the antioxidant activities of phytochemicals have significant impact on hepatoprotection [3840]. Antioxidant scavenging activity against DPPH and H2O2 of active phytochemical in the fruit extracts G. odorata and D. malabarica were assessed in this current study (S1 File). The significant hepatoprotective activities of the active flavonoid compound quercetin from the G. odorata and D. malabarica were observed against CCl4 persuaded hepatic injury in rats by enumerating the total serum albumin, globulin, and bilirubin. These findings were quite comparable with the positive control silymarin. Maintenance of the total serum albumin, globulin, bilirubin levels in blood serum indicates the improved liver condition while comparing with a healthy liver. On the other hand, the lowered levels of SGOT and SGPT in the quercetin treated blood serum content as compared to CCl4 intoxicated mice signifies the improved level of hepatic health. This finding is also corroborated with the SGPT and SGOT levels of silymarin treated rats. Similar study has been reported earlier where the aqueous extracts of Curcuma longa down regulate the serum SGPT and SGOT during hepatoprotection in CCl4 induced hepatic injury [40]. Histopathological studies of quercetin-treated liver tissues exhibited the reduction of polynuclei, granular cytoplasm and regeneration of blood vessels as well as hepatocytes in the CCl4 induced liver (S1 File). Similar observation was found in case of commercial drug silymarin treated liver. Analogous report also suggested that extract of Homalium letestui stem against paracetamol-induced liver injury improved the liver morphology by rearrangements of blood vessels and reduction of inflammatory cells [41, 42]. The upregulation of Hepatocyte growth factor (HGF), the tissue inhibitors metalloproteinase (TIMP1) and matrix metalloproteinase (MMP2) genes Haf, timp1 and mmp2, respectively, in the hepatocytes play a major role in liver fibrosis and damage [42, 43]. A contrasting dominance of down regulation of HGF and metalloproteinase in quercetin-treated liver injured with CCl4 leading to hepatoprotection has confirmed the regeneration of hepatic cells. In silico studies by molecular docking, molecular dynamics and simulations suggested that the quercetin molecule binds with significant binding energy with hepatic microsomal Cytochrome P450 Cyp2E1 which is a major target site for drug metabolism and detoxification. During liver injury by the induction of CCl4, the instability of Cytochrome p450 Cyp2E1 protein is leading to enormous oxidative stress and dysfunction [44]. While the in-silico analysis exhibited that quercetin molecule stabilizes the molecular architecture by making a compact orientation of the constitutive amino acids at the binding site. That leads to a stable conformation of the Cyp2E1 protein which may help to detoxification of CCl4 rapidly and to regain the hepatic health. In addition, quercetin molecule showed significant stable binding with BCL-2 and JAK2 regulatory proteins of cell signaling proteins. BCL-2 activation may lead to deleterious effect on hepatocarcinoma leading to cell death [45]. Therefore, inhibition of BCL-2 leading to prevention of hepatocarcinoma in insilico MD simulation gave suggestive approach for invitro and invivo studies [45]. Similarly, quercetin, in this study exhibited significant binding, stability, and inhibition of BCL-2 in MD simulations corroborated the ameliorating effect in CCl4 induced hapatocarcinoma in rats. Another route to hepatocarcinoma induction by chemical agents is due to JAK2 autophosphorylation leading to inability of STAT3 binding to DNA [46]. In addition, Zhong and coworkers reported the in silico prediction about JAK2 inhibition by natural products and ameliorating activity of hepatocarcinoma [46]. Similar findings have corroborated our results on quercetin displayed significant inhibition in molecular docking. MD simulation studies and free energy landscape (FEL) of JAK2 while bound to quercetin deciphered the good stability of the complex and plausibly allowed to predict quercetin as potent inhibitor against JAK2 during hepatoprotection.

The quercetin-induced stability of the Cyp2E1, BCL-2 and JAK2 perhaps unlocked a novel theragnostic approach for diminishing the effects of CCl4 and reduced hepatotoxicity. Therefore, a detailed study on the dynamic functions of quercetin compound from G. odorata and D. malabarica may pave a potential route towards the identification of a new drug molecule for hepatoprotective function.

Supporting information

S1 File

(PDF)

S2 File

(PDF)

Acknowledgments

Authors are thankful to DST FIST support, Govt. of India to the Department of Botany, Gauhati University and also thankful to Department of Bioengineering and Technology, Gauhati University for proving conducive environment and support to carry out this work. This work is funded by Researchers Supporting Project (RSP- 2021/26), King Saud University, Riyadh, Saudi Arabia.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work is funded by Researchers Supporting Project (RSP- 2021/26), King Saud University, Riyadh, Saudi Arabia.

References

  • 1.Mahli A, Koch A, Czech B, Peterburs P, Lechner A, Haunschild J, et al. Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats. Clinical Phytoscience. 2015. Dec;1(1):1–8. doi: 10.1186/s40816-015-0006-z [DOI] [Google Scholar]
  • 2.Ohta Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K. Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride. Journal of clinical biochemistry and nutrition. 2008;42(2):118–25. doi: 10.3164/jcbn.2008017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cui CP, Wei P, Liu Y, Zhang DJ, Wang LS, Wu CT. The protective role of Hepatopoietin Cn on liver injury induced by carbon tetrachloride in rats. Hepatology Research. 2009. Feb;39(2):200–6. doi: 10.1111/j.1872-034X.2008.00447.x [DOI] [PubMed] [Google Scholar]
  • 4.Adewale OB, Adekeye AO, Akintayo CO, Onikanni A, Sabiu S. Carbon tetrachloride (CCl4)-induced hepatic damage in experimental Sprague Dawley rats: Antioxidant potential of Xylopia aethiopica. Carbon tetrachloride (CCl4)-induced hepatic damage in experimental Sprague Dawley rats: Antioxidant potential of Xylopia aethiopica. 2014;3(2):1–6. [Google Scholar]
  • 5.Hafez MM, Al-Harbi NO, Al-Hoshani AR, Al-Hosaini KA, Al Shrari SD, Al Rejaie SS, et al. Hepato-protective effect of rutin via IL-6/STAT3 pathway in CCl 4-induced hepatotoxicity in rats. Biological research. 2015. Dec;48(1):1–0. doi: 10.1186/s40659-015-0022-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Liu Y, Wen PH, Zhang XX, Dai Y, He Q. Breviscapine ameliorates CCl4 induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation. International Journal of Molecular Medicine. 2018. Aug 1;42(2):755–68. doi: 10.3892/ijmm.2018.3651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Scott Luper ND. A review of plants used in the treatment of liver disease: part 1. Alternative medicine review. 1998;3(6):410–21. [PubMed] [Google Scholar]
  • 8.Scott Luper ND. A review of plants used in the treatment of liver disease: part two. Alternative Medicine Review. 1999;4(3):178–89. [PubMed] [Google Scholar]
  • 9.Cordero-Pérez P, Torres-González L, Aguirre-Garza M, Camara-Lemarroy C, Guzmán-De La Garza F, Alarcón-Galván G, et al. Hepatoprotective effect of commercial herbal extracts on carbon tetrachloride-induced liver damage in Wistar rats. Pharmacognosy research. 2013. Jul;5(3):150. doi: 10.4103/0974-8490.112417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chang SN, Kim SH, Dey DK, Park SM, Nasif O, Bajpai VK, et al. 5-O-Demethylnobiletin Alleviates CCl4-Induced Acute Liver Injury by Equilibrating ROS-Mediated Apoptosis and Autophagy Induction. International journal of molecular sciences. 2021. Jan;22(3):1083. doi: 10.3390/ijms22031083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, Esquivel-Soto J, Esquivel-Chirino C, y González-Rubio MG, et al. Hepatoprotective effect of silymarin. World journal of hepatology. 2014. Mar 27;6(3):144. doi: 10.4254/wjh.v6.i3.144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Miltonprabu S., Tomczyk M., Skalicka-Woźniak K., Rastrelli L., Daglia M., Nabavi S.F., et al., Hepatoprotective effect of quercetin: From chemistry to medicine, Food and Chemical Toxicology. Res. 2016, doi: 10.1016/j.fct.2016.08.034 [DOI] [PubMed] [Google Scholar]
  • 13.Miltonprabu S, Tomczyk M, Skalicka-Woźniak K, Rastrelli L, Daglia M, Nabavi SF, et al. Hepatoprotective effect of quercetin: From chemistry to medicine. Food and Chemical Toxicology. 2017, 108:365–374. doi: 10.1016/j.fct.2016.08.034 [DOI] [PubMed] [Google Scholar]
  • 14.Yousef MI, Omar SA, El-Guendi MI, Abdelmegid LA. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food and Chemical Toxicology. 2010. Nov 1;48(11):3246–61. doi: 10.1016/j.fct.2010.08.034 [DOI] [PubMed] [Google Scholar]
  • 15.Kim SH, Lee JC. Quercetin Protects Hepatocytes against CCl4-Induced Apoptosis via SIRT1 Regulation. 2021. Cell Tiss. Biol. 15: 381–387. doi: 10.1134/S1990519X21040039 [DOI] [Google Scholar]
  • 16.Mondal SK, Chakraborty G, Gupta M, Mazumder UK. In vitro antioxidant activity of Diospyros malabaricaKostel bark. Indian J Exp Biol. 2006. . [PubMed] [Google Scholar]
  • 17.Kalita BC, Das AK, Gupta DD, Hui PK, Gogoi BJ, Tag H. GC-MS analysis of phytocomponents in the methanolic extract of Gynocardia odorata R. Br.-A poisonous plant from Arunachal Himalayan Region. Journal of Pharmacognosy and Phytochemistry. 2018;7(1):2458–63. [Google Scholar]
  • 18.Malik SK, Rehman S, Khan ZD. Evaluation of the biological activities of fruit of Diospyros malabrica (Kostel). Pakistan Journal of Science. 2019. 1;71(4):272–9. [Google Scholar]
  • 19.Trease GE, Evans WC. A textbook of Pharmacognosy. 1978. 11th edition, Bailliere Tendall, London: 15th Ed. London: Saunders Publishers; 2002, pp. 42–393. [Google Scholar]
  • 20.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. Journal of biological chemistry. 1951;193:265–75. [PubMed] [Google Scholar]
  • 21.Ludwig TG, Goldberg HJ. The anthrone method for the determination of carbohydrates in foods and in oral rinsing. Journal of dental research. 1956. Feb;35(1):90–4. doi: 10.1177/00220345560350012301 [DOI] [PubMed] [Google Scholar]
  • 22.Singleton V.L., Rossi J.A. (1965) Colorimetry of total phenolics with phosphomolybdicphosphotungstic acid reagents. Americ. J. Enol. Vitic. 16, 144–158. [Google Scholar]
  • 23.Ansar S, Siddiqi NJ, Zargar S, Ganaie MA, Abudawood M. Hepatoprotective effect of Quercetin supplementation against Acrylamide-induced DNA damage in wistar rats. BMC complementary and alternative medicine. 2016. Dec;16(1):1–5. doi: 10.1186/s12906-016-1322-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Menezes C, Kunal G, Reema N, Satyanarayana D, Jagadish K. Analgesic and anti-inflammatory activity of Ficus glomerata in experimental animal models. International Journal of Pharmaceutical Sciences and Nanotechnology. 2011. Nov 30;4(3):1501–5. [Google Scholar]
  • 25.Amin ZA, Alshawsh MA, Kassim M, Ali HM, Abdulla MA. Gene expression profiling reveals underlying molecular mechanism of hepatoprotective effect of Phyllanthus niruri on thioacetamide-induced hepatotoxicity in Sprague Dawley rats. BMC Complement Altern Med. 2013. Jul 5;13:160. doi: 10.1186/1472-6882-13-160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.B Bedada SK, Neerati P. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. Eur J Clin Pharmacol. 2018. Jan;74(1):91–97. doi: 10.1007/s00228-017-2345-9 [DOI] [PubMed] [Google Scholar]
  • 27.O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J Cheminform. 2011. Oct 7;3:33. doi: 10.1186/1758-2946-3-33 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bowers KJ, Chow DE, Xu H, Dror RO, Eastwood MP, Gregersen BA, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. InSC’06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing 2006 Nov 11 (pp. 43–43). IEEE.
  • 29.Chow E, Rendleman CA, Bowers KJ, Dror RO, Hughes DH, Gullingsrud J, et al. Desmond performance on a cluster of multicore processors. DE Shaw Research Technical Report DESRES/TR—2008-01. 2008 Jul 28.
  • 30.Shivakumar D., Williams J., Wu Y., Damm W., Shelley J., & Sherman W. Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. Journal of Chemical Theory and Computation, (2010). 6(5), 1509–1519. doi: 10.1021/ct900587b [DOI] [PubMed] [Google Scholar]
  • 31.Jorgensen W. L., Chandrasekhar J., Madura J. D., Impey R. W., & Klein M. L. Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, (1983). 79(2), 926–935. doi: 10.1063/1.445869 [DOI] [Google Scholar]
  • 32.Martyna G. J., Tobias D. J. & Klein M. L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. (1994). 101: 4177–4189. doi: 10.1063/1.467468 [DOI] [Google Scholar]
  • 33.Martyna G. J., Klein M. L., and Tuckerman M. Nose-Hoover chains-the canonical ensemble via continuous dynamics. J. Chem. Phys. (1992). 97:2635–2643. doi: 10.1063/1.463940 [DOI] [Google Scholar]
  • 34.Toukmaji, Abdulnour Y. and Board J. Ewald summation techniques in perspective: a survey. Computer Physics Communications. (1996). (95) 73–92. doi: 10.1016/0010-4655(96)00016-1 [DOI] [Google Scholar]
  • 35.Porto Kagami Luciano, Machado das Neves Gustavo, Fernando Saraiva Macedo Timmers Luís, Andrade Caceres Rafael, Lucia Eifler-Lima Vera. Geo-Measures: A PyMOL plugin for protein structure ensembles analysis. Comput Biol Chem. (2020). 24;87:107322. doi: 10.1016/j.compbiolchem.2020.107322 [DOI] [PubMed] [Google Scholar]
  • 36.Piao L, Chen Z, Li Q, Liu R, Song W, Kong R, et al. Molecular dynamics simulations of wild type and mutants of SAPAP in complexed with Shank3. International journal of molecular sciences. 2019. Jan;20(1):224. doi: 10.3390/ijms20010224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Piao L, Chen Z, Li Q, Liu R, Song W, Kong R, et al. Molecular dynamics simulations of wild type and mutants of SAPAP in complexed with Shank3. International journal of molecular sciences. 2019. Jan;20(1):224. doi: 10.3390/ijms20010224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mohan J, Deepa L, Ubaidulla U, Ganesh N. In vitro antioxidant activity of hydro alcoholic extract of Gynocardia odorata roxb. Leaf. International Journal of Research in Pharmaceutical and Nano Sciences. 2013;2(3):351–7. [Google Scholar]
  • 39.Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW, et al. The role of oxidative stress and antioxidants in liver diseases. International journal of molecular sciences. 2015. Nov;16(11):26087–124. doi: 10.3390/ijms161125942 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Xiang C, Teng Y, Yao C, Li X, Cao M, Li X, et al. Antioxidant properties of flavonoid derivatives and their hepatoprotective effects on CCl 4 induced acute liver injury in mice. RSC advances. 2018;8(28):15366–71. doi: 10.1039/C8RA02523A [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hossain MS, Uddin MS, Kabir MT, Begum MM, Koushal P, Herrera-Calderon O, et al. In Vitro Screening for Phytochemicals and Antioxidant Activities of Syngonium Podophyllum L.: an Incredible Therapeutic Plant. Biomed Pharmacol J 2017;10(3). doi: 10.13005/bpj/1229 [DOI] [Google Scholar]
  • 42.Sengupta M, Sharma GD, Chakraborty B. Hepatoprotective and immunomodulatory properties of aqueous extract of Curcuma longa in carbon tetra chloride intoxicated Swiss albino mice. Asian Pacific journal of tropical biomedicine. 2011. Jun 1;1(3):193–9. doi: 10.1016/S2221-1691(11)60026-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Okokon JE, Simeon JO, Umoh EE. Hepatoprotective activity of the extract of Homalium letestui stem against paracetamol-induced liver injury. Avicenna journal of phytomedicine. 2017. Jan;7(1):27. [PMC free article] [PubMed] [Google Scholar]
  • 44.Esposito C, Parrilla B, De Mauri A, Cornacchia F, Fasoli G, Foschi A, Mazzullo T, Plati A, Scudellaro R, Dal Canton A. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney international. 2005. Jun 1;67(6):2143–50. doi: 10.1111/j.1523-1755.2005.00319.x [DOI] [PubMed] [Google Scholar]
  • 45.Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biology. 2015. May 1;44:147–56. doi: 10.1016/j.matbio.2015.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Sahin K, Orhan MD, Avsar T, Durdagi S. Hybrid In Silico and TR-FRET-Guided Discovery of Novel BCL-2 Inhibitors. ACS Pharmacol Transl Sci. 2021. April. 15;4(3):1111–1123. doi: 10.1021/acsptsci.0c00210 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Ghulam Md Ashraf

22 Nov 2021

PONE-D-21-29456Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotectionPLOS ONE

Dear Dr. Baishya,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The authors are advised to address all the comments carefully.

Please submit your revised manuscript by December 25, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ghulam Md Ashraf, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in your Competing Interests section:  

"No"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Partly

Reviewer #5: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: I Don't Know

Reviewer #5: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

Reviewer #5: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

Reviewer #5: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: After reviewing this manuscript entitled: “Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection”. I consider that this article is very interesting but I have some concerns which could be improved in order to generate a major impact in readers:

1. In your study, you include an experimental model of hepatoprotection administrating two extracts. Thereby, I consider that your title should be modify as follows:

• Nonlinear Molecular Dynamics of Quercetin determined in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection.

• However, you could include a similar title that highlights the two fruits involved in your study.

2. Please, include the main objective in your abstract.

3. In page 9 (line 60-61): Scientific names must be italicized. Please, check the whole manuscript.

4. Page 9; Lines 62-64: Authors refers silymarin, which is not the main metabolite of interest in this study. Please, verify your references and only explain the role of quercetin in hepatoprotection.

5. In regard to your introduction: I suggest the followings.

• Try to include only medicinal plants which quercetin has been the responsible effect in the hepatoprotective effect.

• Another paragraph explaining the mechanism of quercetin on the main targets involved in hepatoprotections with updated references.

• Include the main objective in the final paragraph of your introduction and/or secondary objectives.

In material and methods:

1. This sentence should be excluded of the Chemicals section (Molecular interaction and Molecular Dynamics studies were carried out in HP Workstation having (core i7, 3.9 GHZ 85 processor), 32GB RAM, 2TB HDD, NVIDIA Geforce GTX 1650ti graphics processor.)

2. In collection plant: include the GPS data, period of collection, months, where were fruits identified? Any herbarium.

3. In animals’ section: please, include the ethical approval of your institutional committee and reference any international guide for use of experimental animals.

4. In animals’ section: Try to improve your experimental design, how many males and females per group?

5. Type of food or balanced diet?

6. I cannot observe the methodology of the antioxidant activity in your main file. I consider that both antioxidant and histopathological studies should be included in the methodology and referenced.

7. For your antioxidant activity, you could use this reference: Hossain M. S, Uddin M. S, Kabir M. T, Begum M. M, Koushal P, Herrera-Calderon O, Akter R, Asaduzzaman M, Abdel-Daim M. M. In Vitro Screening for Phytochemicals and Antioxidant Activities of Syngonium Podophyllum L.: an Incredible Therapeutic Plant. Biomed Pharmacol J 2017;10(3). https://dx.doi.org/10.13005/bpj/1229

In your results, I cannot observe the table of liver function parameters and biochemical analysis (Table 2) in the main file and supplementary material.

The docking and dynamic analysis is well structured and written.

Your discussion is well planned.

General comments: Authors must correct my comments to improve some aspects such as: Order your methodology. Correct scientific names. Order your figures and tables according to your results. Please, verify and correct the references according to Plos One guide.

Reviewer #2: The manuscript entitled “Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection”

The liver performs number critical functions in the body. Accumulation of free radicals in liver may eventually cause damage, fibrosis, chirrhosis and cancer. Carbon tetrachloride (CCl4) belongs to hepatotoxin is converted to a highly reactive free radical by cytochrome P450 enzymes that causes liver damage. Plant extracts derived quercetin has substantial role in hepatoprotection. HPLC analysis revealed the abundance of quercetin in the fruit extracts of Gynocardia odorata and Diospyros malabarica, were isolated, purified and subjected to liver function analysis on Wistar rats. Post quercetin treatment improved liver function parameters in the hepatotoxic Wistar rats by augmenting bilirubin content, SGOT and SGPT activity. Gene expression profile of quercetin treated rats revealed down regulation of HGF, TIMP1and MMP2 expressed during CCl4 induction. In silico molecular mechanism prediction suggested that quercetin has a high affinity for cell signaling pathway proteins BCL, JAK and Cytochrome P450 CYP2E1, which all play a significant role in CCl4 induced

hepatotoxicity. In silico molecular docking and molecular dynamics simulation have shown that quercetin has a plausible affinity for major signaling proteins in liver. MMGBSA studies have revealed high binding of quercetin (ΔG) -41.48±11.02, -43.53±6.55 and -39.89±5.78 kcal/mol, with BCL-2 , JAK2 and Cyp2E1, respectively which led to better stability of the quercetin bound protein complexes. Therefore, quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL, JAK and Cyp2E1.

Manuscript written very well and extensive studies were done. Instead of having positive points I have seen few silly points which should be rectified before been accepted for publication. My review comments are provided below

1. BCL-2 and JAK2 naming are not uniform throughout the manuscript, uniformity should be maintained throughout the manuscript

2. CCL4, 4 should be in subscript

3. Line 82-83 Himedia India Pvt. Ltd should be incorporated

4. Line 167 Cyp2E1 should be CYP2E1, uniformity must be maintained.

5. Line 241-242 G.odorata and D. malabarica should be in italics as well as in line 248

6. After minute observation I have found in many places few words became conjugated together and that create problematic to read e.g. line 258 “D. malabaricaand” throughout the manuscript. Must be reviewed thoroughly and rectify accordingly.

Reviewer #3: The manuscript entitled “Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection” has engrossed extensive work and well planned manuscript. The results are presented well and authors have well executed each result. Apart from many pros I have seen some major concern which should be rectified or more deeply explained for better understanding. The manuscript can be accepted after the proper answers of the major and minor comments provided by the author. The comments are as follows:

Major Comments:

1. In, molecular docking studies, the major methodological segment must include the population size, selection of best pose based on RMSD clustering and the RMSD tolerance values. The rationale of selecting best dock poses having lowest binding energy score must be mentioned.

Minor Comments:

1. Beginning from abstract, BCL-2 and JAK2 nomenclature have discrepancies throughout the manuscript, somewhere BCL and JAK, in somewhere BCL-2 and JAK2 or in italics, uniformity should be maintained throughout the manuscript.

2. Line 202, MMGBSA equation should be properly aligned in single line

3. In line 241-242, 248 scientific names should be in italics and uniformity should maintain throughout the manuscript.

Reviewer #4: In this manuscript, Ghosh et al has studied the hepatoprotective potential of the Gynocardia odorata and Diospyros malabarica plant extracts derived quercetin. Authors have used qRT-PCR, in silico molecular docking, molecular dynamics simulation and histological methods to elaborate the hepatoprotection potential of the quercetin. However, there are some dots which need to be connected to make the study cleaner and clearer.

1- Line 19- # contributed equally, must be clear with whom author has contributed equally.

2- Line 20 in Abstract- The liver performs number critical functions in the body. Authors should correct this very first line of the manuscript.

3- There are many mistakes like in line 105- (SYS-LC-138, Systronics, India)with the mobile phase. Authors should revise the manuscript extensively to correct the syntax and grammar.

4- In experimental design, on page 11. “D. malabarica (body weight 200 mg/kg), G. odorata (body weight 200 mg/kg), and Silymarin (200 mg/kg body weight) were given orally to these groups of animals at 2, 24 and 48 h interval after the

administration of the last dose of CCl4 (Table 1)”. Authors must ensure that these intermittent doses must fall in the range of human effective dose to follow terms of translational medicine.

5- Quercetin, is very well established for its osteogenic role. Therefore, authors must ensure that there are not any heterotopic ossification or calcification concern, with the administration of the plants extracts, in the vital organs (heart and kidney).

6- In the Fig S2, Authors must keep the scale bar and it would better if authors replace the figures with higher magnification or more clear ones, to see better at cellular morphology.

7- Authors have used frozen liver tissue to isolate the RNA and perform the qRT-PCR. Authors must show the quantification and quality of the isolated RNA.

Reviewer #5: Dear Author

Thanks for the efforts that are put in this work on Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection. This work is a combination of in vivo and in silico CADD which is a welcome development in drug discovery process. The study has revealed that quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL, JAK and Cyp2E confirming it antioxidant potentials as a flavonoid

1. There are few issues that require revision:

Line 20 need to be revised to read; the liver performs a number of critical functions in the body

2. Line 21 and 22 need to also be revised for proper comprehension

1. How was the purity of the extracted quercetin measured?

2. Line 147 should be clarified. The authors reported molecular redocking, but there was no record of any docking in previous sections

3. Line 148-154 is not necessary, the commentary should be taken to discussion section

4. The diagrams are eye catching and interesting

5. Over all, it was a great study and should be accepted after minor revisions are made on the manuscript

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: MD BASHIR UDDIN

Reviewer #4: No

Reviewer #5: Yes: Daniel Ejim Uti PhD. Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medical Sciences, Federal University of Health Sciences, Otukpo, Benue State Nigeria

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Mar 21;17(3):e0263917. doi: 10.1371/journal.pone.0263917.r002

Author response to Decision Letter 0


7 Jan 2022

Response to Reviewers

Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1

: After reviewing this manuscript entitled: “Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection”. I consider that this article is very interesting but I have some concerns which could be improved in order to generate a major impact in readers:

1. In your study, you include an experimental model of hepatoprotection administrating two extracts. Thereby, I consider that your title should be modify as follows:

• Nonlinear Molecular Dynamics of Quercetin determined in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection.

• However, you could include a similar title that highlights the two fruits involved in your study.

Ans: We are thankful to reviewer’s concern and accordingly we have modified the title of the manuscript as suggested.

2. Please, include the main objective in your abstract.

Ans: The principal objective of our study has been incorporated in the abstract segment as “This study highlights the possible mechanism by which quercetin plays significant role in hepatoprotection” in the revised manuscript.

3. In page 9 (line 60-61): Scientific names must be italicized. Please, check the whole manuscript.

Ans: We have rectified the scientific name as per the suggestion in the revised manuscript.

4. Page 9; Lines 62-64: Authors refers silymarin, which is not the main metabolite of interest in this study. Please, verify your references and only explain the role of quercetin in hepatoprotection.

Ans: We are thankful for the suggestion. But we would like to inform that the silymarin was taken as positive control/reference compound in our study which is well established for its hepatoprotection activity and therefore, have referred in the introduction section for better understanding.

5. In regard to your introduction: I suggest the followings.

• Try to include only medicinal plants which quercetin has been the responsible effect in the hepatoprotective effect.

• Another paragraph explaining the mechanism of quercetin on the main targets involved in hepatoprotections with updated references.

• Include the main objective in the final paragraph of your introduction and/or secondary objectives.

Ans: Revisions have been incorporated in the manuscript as:

• The plants reported in the introduction and discussion sections are rich source of quercetin and many of them were already reported elsewhere for hepatoprotective activity.

• As per the suggestion, mechanism has been displayed in the separate paragraph.

• Main objective of the study has been highlighted in the revised manuscript as per the suggestion.

In material and methods:

1. This sentence should be excluded of the Chemicals section (Molecular interaction and Molecular Dynamics studies were carried out in HP Workstation having (core i7, 3.9 GHZ 85 processor), 32GB RAM, 2TB HDD, NVIDIA Geforce GTX 1650ti graphics processor.)

Ans: As per the reviewers suggestion details of the computational infrastructure has been removed from the materials section in the revised manuscript.

2. In collection plant: include the GPS data, period of collection, months, where were fruits identified? Any herbarium.

Ans: GPS location data has been incorporated in the revised manuscript as per suggestion. The collected plants were subjected to harbarium preparation and followed by identification at GUBH, the Dept. of Botany, Gauhati University, Assam, India. Nevertheless, accession numbers were assigned to the individual plants as D. malabarica (Acc. No. 18071 dt.04.11.2015) and G. odorata (Ac.No. 18072dt.04.11.2015). These statements have been incorporated in the revised manuscript.

3. In animals’ section: please, include the ethical approval of your institutional committee and reference any international guide for use of experimental animals.

Ans: Ethical approval statements have already been included in the previous version of the manuscript in the ethical approval section.

4. In animals’ section: Try to improve your experimental design, how many males and females per group?

Ans: In animals section, experimental setup has been improved for better understanding. In each group of 6 rats, 3 male and 3 females were taken and accordingly revised in the manuscript.

5. Type of food or balanced diet?

Ans: “Animal models were fed with Normal pellet diet” and has been incorporated in the revised manuscript.

6. I cannot observe the methodology of the antioxidant activity in your main file. I consider that both antioxidant and histopathological studies should be included in the methodology and referenced.

Ans: The methodology of antioxidant activity and histopathological studies already incorporated in the supplementary file and a statement referencing that has been incorporated in the revised version.

7. For your antioxidant activity, you could use this reference: Hossain M. S, Uddin M. S, Kabir M. T, Begum M. M, Koushal P, Herrera-Calderon O, Akter R, Asaduzzaman M, Abdel-Daim M. M. In Vitro Screening for Phytochemicals and Antioxidant Activities of Syngonium Podophyllum L.: an Incredible Therapeutic Plant. Biomed Pharmacol J 2017;10(3). https://dx.doi.org/10.13005/bpj/1229

Ans: Thank you for your suggestion. We have incorporated this reference in the discussion as reference No.41.

In your results, I cannot observe the table of liver function parameters and biochemical analysis (Table 2) in the main file and supplementary material.

Ans: The table of liver function parameters was shown in Table 2 in the original manuscript. The Biochemical analysis was shown in TableST2 in the supplementary file.

The docking and dynamic analysis is well structured and written.

Your discussion is well planned.

Ans: We are grateful to the reviewer for appreciating our work.

General comments: Authors must correct my comments to improve some aspects such as: Order your methodology. Correct scientific names. Order your figures and tables according to your results. Please, verify and correct the references according to Plos One guide.

Ans: We have done modification to our revised version of the manuscript as suggested.

Reviewer #2:

The manuscript entitled “Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection”

The liver performs number critical functions in the body. Accumulation of free radicals in liver may eventually cause damage, fibrosis, chirrhosis and cancer. Carbon tetrachloride (CCl4) belongs to hepatotoxin is converted to a highly reactive free radical by cytochrome P450 enzymes that causes liver damage. Plant extracts derived quercetin has substantial role in hepatoprotection. HPLC analysis revealed the abundance of quercetin in the fruit extracts of Gynocardia odorata and Diospyros malabarica, were isolated, purified and subjected to liver function analysis on Wistar rats. Post quercetin treatment improved liver function parameters in the hepatotoxic Wistar rats by augmenting bilirubin content, SGOT and SGPT activity. Gene expression profile of quercetin treated rats revealed down regulation of HGF, TIMP1and MMP2 expressed during CCl4 induction. In silico molecular mechanism prediction suggested that quercetin has a high affinity for cell signaling pathway proteins BCL, JAK and Cytochrome P450 CYP2E1, which all play a significant role in CCl4 induced

hepatotoxicity. In silico molecular docking and molecular dynamics simulation have shown that quercetin has a plausible affinity for major signaling proteins in liver. MMGBSA studies have revealed high binding of quercetin (ΔG) -41.48±11.02, -43.53±6.55 and -39.89±5.78 kcal/mol, with BCL-2 , JAK2 and Cyp2E1, respectively which led to better stability of the quercetin bound protein complexes. Therefore, quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL, JAK and Cyp2E1.

Manuscript written very well and extensive studies were done. Instead of having positive points I have seen few silly points which should be rectified before been accepted for publication. My review comments are provided below

1. BCL-2 and JAK2 naming are not uniform throughout the manuscript, uniformity should be maintained throughout the manuscript.

Ans: To maintain the uniformity we have done the rectifications throughout the manuscript.

2. CCL4, 4 should be in subscript

Ans: All CCL4 are subscripted in the revised manuscript as per the reviewers suggestion.

3. Line 82-83 Himedia India Pvt. Ltd should be incorporated

Ans: Incorporation has been done as per the reviewer’s suggestion.

4. Line 167 Cyp2E1 should be CYP2E1, uniformity must be maintained.

Ans: Uniformity of Cyp2E1 is maintained throughout the revised manuscript as per the reviewer’s suggestion.

5. Line 241-242 G.odorata and D. malabarica should be in italics as well as in line 248

Ans: Italicizing of the scientific names of plants G.odorata and D. malabarica are made in the revised manuscript

6. After minute observation I have found in many places few words became conjugated together and that create problematic to read e.g. line 258 “D. malabaricaand” throughout the manuscript. Must be reviewed thoroughly and rectify accordingly.

Ans: Changes have been made in the revised manuscript as per the suggestion.

Reviewer #3:

The manuscript entitled “Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection” has engrossed extensive work and well planned manuscript. The results are presented well and authors have well executed each result. Apart from many pros I have seen some major concern which should be rectified or more deeply explained for better understanding. The manuscript can be accepted after the proper answers of the major and minor comments provided by the author. The comments are as follows:

Major Comments:

1. In, molecular docking studies, the major methodological segment must include the population size, selection of best pose based on RMSD clustering and the RMSD tolerance values. The rationale of selecting best dock poses having lowest binding energy score must be mentioned.

Ans: In methodological segments statement has been introduced as “During molecular docking studies, three replicates were performed having the total number of solutions computed 50 in each case, with population size 500, number of evaluations 2500000, maximum number of generations 27000 and rest the default parameters were allowed. After docking, the RMSD clustering maps were obtained by re-clustering with a clustering tolerance 0.25 Å, 0.5 Å and 1 Å, respectively, in order to obtain the best cluster having lowest energy score with high number of populations.” in the revised mansucript as per the suggestion

In results section a new statement has been incorporated in the revised manuscript results section of molecular dcoking for better understanding of the rationale of selection of best dock pose as “The best dock pose was seleccted based on low RMSD tolerance 0.5 Å and binding energy having maximum within that RMSD cluster”

Minor Comments:

1. Beginning from abstract, BCL-2 and JAK2 nomenclature have discrepancies throughout the manuscript, somewhere BCL and JAK, in somewhere BCL-2 and JAK2 or in italics, uniformity should be maintained throughout the manuscript.

Ans: All rectifications are done in the revised manuscript as per the suggestion.

2. Line 202, MMGBSA equation should be properly aligned in single line

Ans: MMGBSA equation is properly aligned in a single line in the revised manuscript.

3. In line 241-242, 248 scientific names should be in italics and uniformity should maintain throughout the manuscript.

Ans: Scientific names are italicized at the respective positions throughout the revised manuscript as per the suggestion

Reviewer #4:

In this manuscript, Ghosh et al has studied the hepatoprotective potential of the Gynocardia odorata and Diospyros malabarica plant extracts derived quercetin. Authors have used qRT-PCR, in silico molecular docking, molecular dynamics simulation and histological methods to elaborate the hepatoprotection potential of the quercetin. However, there are some dots which need to be connected to make the study cleaner and clearer.

1- Line 19- # contributed equally, must be clear with whom author has contributed equally.

Ans: As per the reviewer’s suggestion equal contribution is marked “†” to Arabinda Ghosh and Pranjal Sarmah in the revised mascript for better undersanding.

2- Line 20 in Abstract- The liver performs number critical functions in the body. Authors should correct this very first line of the manuscript.

Ans: This statement has been modified as per the reviewer’s suggestion in the revised manuscript.

3- There are many mistakes like in line 105- (SYS-LC-138, Systronics, India) with the mobile phase. Authors should revise the manuscript extensively to correct the syntax and grammar.

Ans: The statement and the grammar has been thoroughly checked and rectified in the revised manuscript.

4- In experimental design, on page 11. “D. malabarica (body weight 200 mg/kg), G. odorata (body weight 200 mg/kg), and Silymarin (200 mg/kg body weight) were given orally to these groups of animals at 2, 24 and 48 h interval after the

administration of the last dose of CCl4 (Table 1)”. Authors must ensure that these intermittent doses must fall in the range of human effective dose to follow terms of translational medicine.

Ans: We have followed the OECD(423) guideline while designing the experiment as mentioned in the methodology section of our manuscript. The dose selection was done by strictly following the guideline. Further, we found that the dose falls in the range of Human Equivalent Dose (HED) based on the following standard conversion formula :

HED (mg/Kg) = Animal Dose(mg/Kg) x (Animal Km/Human Km) [Nair and Jacob, 2016; Journal Basic Clinical pharmacy]

5- Quercetin, is very well established for its osteogenic role. Therefore, authors must ensure that there are not any heterotopic ossification or calcification concern, with the administration of the plants extracts, in the vital organs (heart and kidney).

Ans: We appreciate the reviewer for his/her concern. However, as our work focuses the mechanistic role of quercetin in hepatoprotection, so, we have not included the consequent impact of these plant extracts on other organs in the present study.

On the other hand, the most recent report revealed that the quercetin helps in preventing heterotopic ossification (Li et al, 2021; Frontiers in Immunology Vol:2; doi: 10.3389/fimmu.2021.649285). Similarly, it was also reported that quercetin significantly lower the severity of ossification (Chang et al . 2017; BioMed Res Int.; doi: 1155/2017/5716204).

6- In the Fig S2, Authors must keep the scale bar and it would better if authors replace the figures with higher magnification or more clear ones, to see better at cellular morphology.

Ans: The Fig S2 has been modified as per the suggestion of the Reviewer and incorporated in the revised supplementary file S1.

7- Authors have used frozen liver tissue to isolate the RNA and perform the qRT-PCR. Authors must show the quantification and quality of the isolated RNA.

Ans: We have incorporated the quantification and quality of the isolated RNA in the revised version of the manuscript and the data were shown as supplementary file.

The 260/280 ratio for the RNA isolated from the liver tissue samples ranged from 2.08-2.14 suggesting good quality RNA (Supplementary File S2, Table ST3). The integrity of RNA was checked on Agarose gel showing discrete 28S and 18S ribosomal RNA band on each sample suggesting that the RNA in each case was intact and could be used for qPCR analysis (Supplementary File S2, Fig S3).

Reviewer #5:

Dear Author

Thanks for the efforts that are put in this work on Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection. This work is a combination of in vivo and in silico CADD which is a welcome development in drug discovery process. The study has revealed that quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL, JAK and Cyp2E confirming it antioxidant potentials as a flavonoid

1. There are few issues that require revision: Line 20 need to be revised to read; the liver performs a number of critical functions in the body

Ans: The statement has been revised in the manuscript as “Liver performs number of critical physiological functions in human system”

2. Line 21 and 22 need to also be revised for proper comprehension

Ans: Statement has been revised as “Intoxication of liver leads to accumulation of free radicals that eventually cause damage, fibrosis, cirrhosis and cancer.”

1. How was the purity of the extracted quercetin measured?

Ans: Purity of the extracted quercetin from fruit extracts were determined by comparing with the standard Quercetin in HPLC.

2. Line 147 should be clarified. The authors reported molecular redocking, but there was no record of any docking in previous sections

Ans: This statement meant the docking performed first using Autodock 4.2 and then performed in Schrodinger 2018-4 using glide and QM docking. Details of docking already mentioned in methods section.

3. Line 148-154 is not necessary, the commentary should be taken to discussion section

Ans: The commentary has been removed from methods section as per the reviewer’s suggestion, and similar statements were already reported in the discussion section in the previous version of the manuscript.

4. The diagrams are eye catching and interesting

Ans: We are thankful to the reviewer for appreciating our work.

5. Over all, it was a great study and should be accepted after minor revisions are made on the manuscript

Ans: We are grateful to the reviewer for appreciating our work.

Attachment

Submitted filename: Response to Reviewers.doc

Decision Letter 1

Ghulam Md Ashraf

31 Jan 2022

Nonlinear Molecular Dynamics of Quercetin in Gynocardia odorata and Diospyros malabarica fruits : Its mechanistic role in hepatoprotection

PONE-D-21-29456R1

Dear Dr. Baishya,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ghulam Md Ashraf, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

The authors have addressed all the comments and the manuscript is now acceptable for publication.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript entitled "Nonlinear Molecular Dynamics of Quercetin in Gynocardia odorata and Diospyros

malabarica fruits : Its mechanistic role in hepatoprotection" has been improved according to my comments and could be accepted in its current form.

Reviewer #2: All comments were properly addressed and clarified. So, the manuscript may be accepted in this Journal

Reviewer #3: All comments are well addressed and could be Accepted for publication. Editing manuscript Language also well improved.

Reviewer #4: Ghosh et. al, have beautifuly addressed, point by point, all my comments and corrected the manuscript accordingly.

Reviewer #5: Dear Author

Thanks for the efforts that are put in this work on Nonlinear Molecular Dynamics of quercetin: Its mechanistic role in hepatoprotection. This work is a combination of in vivo and in silico CADD which is a welcome development in drug discovery process. The study has revealed that quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL, JAK and Cyp2E confirming it antioxidant potentials as a flavonoid. The minor issues raised in the earlier manuscript were well addressed in this revised copy. Over all, it was a great study and should be accepted for publication

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

Reviewer #5: Yes: Daniel Ejim Uti (PhD.)

Acceptance letter

Ghulam Md Ashraf

10 Feb 2022

PONE-D-21-29456R1

Nonlinear Molecular Dynamics of Quercetin in Gynocardia odorata and Diospyros malabarica fruits : Its mechanistic role in hepatoprotection

Dear Dr. Baishya:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ghulam Md Ashraf

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    S2 File

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.doc

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES